TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.

Otros idiomas Tonghua Dongbao Pharmaceutical Co., Ltd.

Acciones

600867

CNE000000H87

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
10,59 ^CNY	+4,03 %		+5,58 %	-2,22 %

26/04	Tonghua Dongbao Pharmaceutical Co. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
29/03	El beneficio de Dongbao Pharma en 2023 cae un 26	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Dongbao Pharma's 2023 Profit Drops 26%	29/03
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/01
Dongbao Pharma Unit's Gout Drug Clinical Study Achieves Primary Endpoint	17/01
Dongbao Pharmaceutical's Unit Gets Nod to Trial Diabetes Drug	27/12
Dongbao Pharmaceutical Unit Gets Nod to Trial Diabetes Drug	12/12
Tonghua Dongbao Pharma Unit Enrolls First Subject for Clinical Trial of Diabetes Drug	06/12
Tonghua Dongbao Pharma Registers Diabetes Drug	05/12
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Tonghua Dongbao Pharmaceutical's Insulin Injection Shows Positive Results in German Trial	24/10/23
Adocia : en nette hausse après des résultats positifs contre le diabète	23/10/23
Adocia Announces its Partner Tonghua Dongbao Releases Positive Results on the Three Clinical Studies Conducted on BioChaperone Combo THDB0207 Formulation Containing Insulin Glargine and Insulin Lispro from Tonghua Dongbao	23/10/23
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Announces an Exclusive Licensing Agreement with Tonghua Dongbao Pharmaceutical Co., Ltd. to Commercialize Three Insulin Biosimilars - Insulin Aspart, Insulin Lispro, and Insulin Glargine in the U.S	21/09/23
Tonghua Dongbao Pharmaceutical Co., Ltd.(XSSC:600867) added to S&P Global BMI Index	18/09/23
Tonghua Dongbao Pharmaceutical Co., Ltd.(XSSC:600867) added to FTSE All-World Index	18/09/23
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21/08/23
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Tonghua Dongbao Pharmaceutical Enrolls First Subject for Phase II Trial of Gout Drug; Shares Rose 4%	08/02/23
Tonghua Dongbao Pharma’s Net Profit Jumps 21% Despite Revenue Drop	07/02/23
Tonghua Dongbao Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	06/02/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tonghua Dongbao Pharmaceutical Co., Ltd.

Acciones

600867

CNE000000H87

Otros idiomas

Filtros